Biomerica Reports Q2 2024 EPS $(0.09) Up From $(0.12) YoY, Revenue $1.6M Up From $1.5M YoY
Portfolio Pulse from Benzinga Newsdesk
Biomerica Inc. reported its Q2 2024 earnings with an EPS of $(0.9), an improvement from $(0.12) in the same quarter of the previous year. Revenue increased to $1.6 million from $1.5 million year-over-year.

January 16, 2024 | 1:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biomerica Inc. reported a narrower loss per share in Q2 2024 compared to the previous year and a marginal increase in revenue.
The improvement in EPS, despite still being negative, indicates a reduction in losses which could be viewed positively by investors. The increase in revenue, although slight, shows growth in sales which may also be seen as a positive indicator for the company's performance. These factors combined could lead to a short-term positive impact on BMRA's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100